NCT00378586UnknownNot Applicable
Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Herlev Hospital
- Enrollment
- 30
- Locations
- 1
Study Overview
Brief Summary
Life-threatening infection impairs bloodflow to the gut, thereby causing less delivery of oxygen. This leads to increased formation of different inflammatory and infectious markers.
The investigators hypothesize, therefore, that there is a significant difference in the concentrations of inflammatory and infectious markers in the rectal mucosa between patients with septic shock and healthy controls.
Study Design
- Study Type
- Observational
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Septic shock
Exclusion Criteria
- •Age < 18 years
- •No next of kin
- •Pathology of the descending or sigmoid colon or rectum
- •Pregnancy
- •1st degree relatives with inflammatory bowel disease
- •Severe coagulopathy
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Lactic Acid in the Rectum and Life-Threatening InfectionSeptic ShockNCT00197938Herlev Hospital130
Terminated
Not Applicable
Mitochondrial Dysfunction of Alveolar and Circulating Immune Cells During Acute Respiratory Distress Syndrome: Impact of Infectious Aggression and Alveolar Stretching as a Result of Mechanical Ventilation.Lung DiseasesMechanical VentilationBronchoalveolar LavageNCT03955887Centre Hospitalier Universitaire Dijon28
Completed
Not Applicable
Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic ShockSeptic ShockNCT03456180Università Politecnica delle Marche10
Recruiting
Not Applicable
Clinical Research on Shenfu Injection in Septic PatientsSepsisNCT06157320Ruijin Hospital40
Completed
Not Applicable
Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal OriginSepsisNCT01530932Universitätsmedizin Mannheim20
